Arizona State Senators Introduce Latest 340B Contract Pharmacy Bill

Two influential Arizona state senators recently introduced a bill that would prohibit drugmaker restrictions on 340B contract pharmacy use.
Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HIV/AIDS Group Continues Legal Fight with Apexus Over 340B Prime Vendor Contract

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

340B Working Table's lobbying disclosure filing.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Iowa 340B Contract Pharmacy Bill Introduced; Companion Bills Debut in West Virginia, Oklahoma

Iowa is the latest state to introduce a bill to shield 340B contract pharmacy arrangements from manufacturer restrictions.
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

$7.8 Billion in Refunds from Underpayments to 340B Hospitals Begin to Roll In

A map of Medicare administrative contractors' (MAC's) jurisdictions. MACs in more than half the states have begun to issue refunds to 340B hospitals for unlawful Medicare cuts from 2018-2022.
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Latest Cassidy Probe Adds to Growing Scrutiny of 340B Contract Pharmacies, TPAs

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.
An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More States Introduce 340B Contract Pharmacy Protection Bills

Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Makers Issue Record Number of 340B Refunds in 2023, Merck First to Refund in 2024

Drugmakers issued a record 41 refunds to 340B covered entities in 2023.
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live